Predictive Genetic Testing and Consumer Genomics Market, By Test (Predictive Testing, Consumer Genomics, and Wellness Genomics), By Application, By Setting, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Predictive Genetic Testing and Consumer Genomics Market size was valued at USD 4,790.43 Million in 2024, expanding at a CAGR of 12.71% from 2024 to 2032.
Predictive genetic testing involves analyzing an individual’s DNA to evaluate the risk of developing specific genetic conditions before any symptoms are present. This type of testing is commonly used in clinical settings to identify gene mutations associated with diseases such as cancer and cardiovascular disorders, allowing for early intervention and informed healthcare decisions.
Consumer genomics, on the other hand, refers to direct-to-consumer (DTC) genetic testing services that offer insights into ancestry, physical traits, wellness factors, and potential health risks. These tests are typically ordered online and conducted at home using saliva samples. While consumer genomics makes genetic information more accessible to the general public, it often lacks the clinical accuracy and personalized interpretation provided by healthcare professionals. Both approaches contribute to the advancement of personalized healthcare, enabling individuals to better understand their genetic makeup and make proactive choices regarding their health and lifestyle.
Predictive Genetic Testing and Consumer Genomics Market- Market Dynamics
Growing Demand for Personalized Healthcare
The growing emphasis on personalized healthcare is significantly propelling the predictive genetic testing and consumer genomics market. As individuals increasingly prioritize proactive health management, there is a rising demand for personalized insights that can guide lifestyle choices, preventive strategies, and treatment decisions. Predictive genetic testing plays a critical role in identifying inherited risks for conditions such as cancer, cardiovascular disease, and neurodegenerative disorders—often before symptoms arise—enabling early intervention and improved outcomes. The Ayushman Bharat Yojana, a flagship national health protection scheme, aims to provide insurance coverage to over 100 million low-income families, significantly enhancing access to diagnostic and treatment services.
Meanwhile, consumer genomics has democratized access to genetic information through affordable, at-home testing kits that offer insights into ancestry, health risks, and wellness traits. The convergence of greater public awareness about genetic predispositions, advancements in sequencing technologies, and declining testing costs has made genetic testing more accessible than ever. This trend is further reinforced by the integration of genetic data into digital health ecosystems, including mobile health apps, telemedicine platforms, and personalized wellness programs. Together, predictive genetic testing and consumer genomics are reshaping the healthcare landscape, making precision medicine a practical reality for a broader population.
Predictive Genetic Testing and Consumer Genomics Market- Segmentation Analysis:
The global Predictive Genetic Testing and Consumer Genomics Market is divided into four categories: Test, Application, setting and Region.
The predictive genetic testing and consumer genomics market is segmented by type into Predictive Testing, Consumer Genomics, and Wellness Genomics. Predictive testing is used to identify genetic predispositions to inherited diseases before symptoms appear, allowing for early intervention and preventive healthcare. Wellness genomics focuses on tailoring lifestyle, fitness, and nutrition recommendations based on a person’s genetic makeup. However, it is Consumer Genomics that dominates the market, driven by its accessibility, affordability, and increasing consumer interest in personal health insights and ancestry information. The rise of direct-to-consumer (DTC) platforms, such as 23andMe and AncestryDNA, coupled with aggressive digital marketing and broad online availability, has led to widespread adoption. According to data from the U.S. Food and Drug Administration (FDA), over 30 million people in the United States have used at-home genetic testing kits as of 2023, with consumer genomics accounting for the vast majority of these tests. This reflects a growing trend of individuals taking a proactive approach to health and wellness, further solidifying consumer genomics\' leading position in the market.
By application, the market is categorized into areas such as Breast & Ovarian Cancer, Cardiovascular Screening, Diabetic Screening & Monitoring, Colon Cancer, Parkinsonism/Alzheimer’s Disease, Urologic/Prostate Cancer Screening, Orthopedic & Musculoskeletal Disorders, Other Cancer Screening, and Other Diseases. These applications focus on detecting genetic markers associated with disease risk, which enables early diagnosis, personalized care plans, and targeted prevention strategies. Among them, Breast & Ovarian Cancer leads the market, largely due to the high public awareness of BRCA1 and BRCA2 mutations, which significantly elevate cancer risk. Government-endorsed initiatives and nonprofit campaigns have amplified awareness, making genetic screening for these mutations a routine part of preventive healthcare. According to the Centers for Disease Control and Prevention (CDC), more than 1 in 400 people in the U.S. carry a BRCA mutation, and screening rates have increased by over 25% in the past five years, spurred by insurance coverage expansion and healthcare provider adoption. This growth underscores the critical role of genetic testing in cancer prevention and early detection, particularly in populations at elevated risk.
Predictive Genetic Testing and Consumer Genomics Market- Geographical Insights
The predictive genetic testing and consumer genomics market is geographically distributed across key regions, including North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. Each region is shaped by unique healthcare dynamics, regulatory environments, and levels of consumer engagement, with growth driven by both national policies and private sector innovation.
North America remains the dominant player in the global market, primarily led by the United States. The region benefits from a highly developed healthcare infrastructure, strong investments in research and development, and widespread consumer awareness of genetic testing. Key industry leaders such as 23andMe, AncestryDNA, and Myriad Genetics have propelled market growth through innovative direct-to-consumer offerings and personalized health services. The integration of genetic testing into mainstream healthcare, along with increasing adoption of precision medicine, has expanded accessibility and demand across both clinical and non-clinical settings. Favorable regulatory frameworks and insurance coverage—particularly for hereditary cancer screening—support clinical uptake. The U.S. leads the regional market with proactive health policies and robust private-sector participation, while Canada continues to emerge as a strong contributor, driven by government-funded genomics initiatives and research programs such as Genome Canada. Together, North America\'s technological leadership, high public engagement, and policy support underpin its market dominance.
Europe stands as the second-largest market, led by countries such as the United Kingdom, Germany, and France. The region benefits from a combination of public health investment, growing digitization in healthcare, and rising consumer interest in preventive and personalized medicine. Notably, national efforts like the UK’s 100,000 Genomes Project have significantly advanced genetic research and infrastructure, increasing public awareness and access to genetic testing services. European governments are actively supporting the integration of genomics into routine healthcare through national strategies and funding. Strict data protection regulations under the General Data Protection Regulation (GDPR) enhance consumer trust and data security, encouraging adoption of genetic services. Additionally, increasing prevalence of diseases such as cancer and cardiovascular disorders has prompted expanded screening efforts. Companies in the European market are focusing on enhancing service accessibility, often in collaboration with public health systems, positioning the region for sustained growth in the years ahead.
Predictive Genetic Testing and Consumer Genomics Market- Competitive Landscape:
The competitive landscape of the predictive genetic testing and consumer genomics market is shaped by a mix of well-established biotechnology and diagnostics companies alongside agile, innovation-driven firms. Leading players such as 23andMe, Myriad Genetics, Roche, Abbott, Agilent Technologies, and Thermo Fisher Scientific maintain a strong market presence through advanced genomic platforms, diversified product portfolios, and significant investments in research and development. These companies prioritize regulatory compliance and technological advancement to improve test accuracy, expand clinical and consumer applications, and retain a competitive edge.
Emerging firms and research-oriented companies, including BGI, Illumina, and Bio-Rad, are driving innovation in high-throughput sequencing, cost-efficient testing, and cutting-edge applications such as multiomics and personalized diagnostics. Their focus on scalable solutions and advanced analytics is reshaping the way genetic data is generated and utilized.
Recent Developments:
- March 2025 – 23andMe filed for Chapter 11 bankruptcy, citing financial difficulties and the impact of a major data breach that compromised the personal information of approximately 6.9 million users. As part of its restructuring plan, the company closed its San Francisco headquarters and issued layoff notices to 250 employees.
- February 2025 – Myriad Genetics announced a strategic collaboration with PATHOMIQ, a health technology firm specializing in artificial intelligence. The partnership is focused on enhancing Myriad’s Prolaris test for prostate cancer by integrating AI-driven analytics, with the goal of improving diagnostic precision and supporting more personalized treatment decisions.
- August 2024 – Illumina revealed a strategic roadmap aimed at accelerating revenue growth over the next three years. The plan emphasizes innovations in multiomics and single-cell sequencing, two rapidly advancing fields in genomics. In addition, Illumina entered a research partnership with the Broad Institute to further develop single-cell sequencing technologies and expand their applications in clinical and research settings.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PREDICTIVE GENETIC TESTING AND CONSUMER GENOMICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- 23andMe, Inc.
- Myriad Genetics, Inc.
- F. Hoffmann-La Roche Ltd
- Abbott
- Agilent Technologies, Inc.
- Thermo Fisher Scientific Inc.
- BGI
- Bio-Rad Laboratories, Inc.
- Illumina, Inc.
- ARUP Laboratories
- Others
GLOBAL PREDICTIVE GENETIC TESTING AND CONSUMER GENOMICS MARKET, BY TEST - MARKET ANALYSIS, 2019 - 2032
- Predictive Testing
- Genetic Susceptibility Test
- Predictive Diagnostics
- Population Screening
- Consumer Genomics
- Wellness Genomics
- Nutria Genetics
- Skin & Metabolism Genetics
- Others
GLOBAL PREDICTIVE GENETIC TESTING AND CONSUMER GENOMICS MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032
- Breast & Ovarian Cancer
- Cardiovascular screening
- Diabetic Screening & Monitoring
- Colon Cancer
- Parkinsonism / Alzheimer’s Disease
- Urologic screening/ Prostate cancer screening
- Orthopedic & Musculoskeletal
- Other cancer screening
- Other diseases
GLOBAL PREDICTIVE GENETIC TESTING AND CONSUMER GENOMICS MARKET, BY SETTING - MARKET ANALYSIS, 2019 - 2032
- DTC
- Professional
GLOBAL PREDICTIVE GENETIC TESTING AND CONSUMER GENOMICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Predictive Genetic Testing and Consumer Genomics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Predictive Genetic Testing and Consumer Genomics Market Snippet by Test
2.1.2. Predictive Genetic Testing and Consumer Genomics Market Snippet by Application
2.1.3. Predictive Genetic Testing and Consumer Genomics Market Snippet by Setting
2.1.4. Predictive Genetic Testing and Consumer Genomics Market Snippet by Country
2.1.5. Predictive Genetic Testing and Consumer Genomics Market Snippet by Region
2.2. Competitive Insights
3. Predictive Genetic Testing and Consumer Genomics Key Market Trends
3.1. Predictive Genetic Testing and Consumer Genomics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Predictive Genetic Testing and Consumer Genomics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Predictive Genetic Testing and Consumer Genomics Market Opportunities
3.4. Predictive Genetic Testing and Consumer Genomics Market Future Trends
4. Predictive Genetic Testing and Consumer Genomics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Predictive Genetic Testing and Consumer Genomics Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Predictive Genetic Testing and Consumer Genomics Market Landscape
6.1. Predictive Genetic Testing and Consumer Genomics Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Predictive Genetic Testing and Consumer Genomics Market – By Test
7.1. Overview
7.1.1. Segment Share Analysis, By Test, 2023 & 2032 (%)
7.1.2. Predictive Testing
7.1.2.1. Genetic Susceptibility Test
7.1.2.2. Predictive Diagnostics
7.1.2.3. Population Screening
7.1.3. Consumer Genomics
7.1.4. Wellness Genomics
7.1.4.1. Nutria Genetics
7.1.4.2. Skin & Metabolism Genetics
7.1.4.3. Others
8. Predictive Genetic Testing and Consumer Genomics Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
8.1.2. Breast & Ovarian Cancer
8.1.3. Cardiovascular screening
8.1.4. Diabetic Screening & Monitoring
8.1.5. Colon Cancer
8.1.6. Parkinsonism / Alzheimer’s Disease
8.1.7. Urologic screening/ Prostate cancer screening
8.1.8. Orthopedic & Musculoskeletal
8.1.9. Other cancer screening
8.1.10. Other diseases
9. Predictive Genetic Testing and Consumer Genomics Market – By Setting
9.1. Overview
9.1.1. Segment Share Analysis, By Setting, 2023 & 2032 (%)
9.1.2. DTC
9.1.3. Professional
10. Predictive Genetic Testing and Consumer Genomics Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Predictive Genetic Testing and Consumer Genomics Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Predictive Genetic Testing and Consumer Genomics Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.3.8. France
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. France Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.3.8.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.8.5. France Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.3.9. Italy
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. Italy Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.3.9.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.9.5. Italy Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.3.10. Spain
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. United Kingdom Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.3.10.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.10.5. United Kingdom Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.3.11. United Kingdom
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.3. United Kingdom Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.3.11.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.11.5. United Kingdom Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.3.12. Russia
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.2. Russia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.3.12.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.12.4. Russia Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.3.13. Netherlands
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.2. Netherlands Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.3.13.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.13.4. Netherlands Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.3.14. Sweden
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.2. Sweden Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.3.14.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.14.4. Sweden Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.3.15. Poland
10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.2. Poland Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.16.5. Rest of the Europe Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Predictive Genetic Testing and Consumer Genomics Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.7.5. India Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.8.5. China Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.4.9. South Korea
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. South Korea Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.4.9.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.9.5. South Korea Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.4.10. Japan
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. Japan Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.4.10.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.10.5. Japan Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Predictive Genetic Testing and Consumer Genomics Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Predictive Genetic Testing and Consumer Genomics Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Setting, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Predictive Genetic Testing and Consumer Genomics Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. 23andMe, Inc.
11.2.2. Myriad Genetics, Inc.
11.2.3. F. Hoffmann-La Roche Ltd
11.2.4. Abbott
11.2.5. Agilent Technologies, Inc.
11.2.6. Thermo Fisher Scientific Inc.
11.2.7. BGI
11.2.8. Bio-Rad Laboratories, Inc.
11.2.9. Illumina, Inc.
11.2.10. ARUP Laboratories
11.2.11. Others
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
